《全日速報》恆指全日收報24,792點 升73點; 恆生科技指數全日收報5,662點 升45點 藥明生物升逾6% 亞信科技創新高 成交暢旺
恆指全日收24,792點,升73點或0.3%。恆生科技指數報5,662點,升45點或0.8%。國指升32點或0.4%,報8,711點。大市成交額1,046.02億元。
活躍重磅股表現:
友邦(01299.HK) 收89.3元,上升1.1%;
美團(03690.HK) 收220.8元,上升0.6%;
騰訊(00700.HK) 收479元,上升0.6%;
港交所(00388.HK) 收437.4元,下跌0.5%;
阿裏巴巴(09988.HK) 收123元,上升0.4%;
平安(02318.HK) 收66.6元,上升0.1%;
建行(00939.HK) 收6元,無升跌;
異動恆指及國指成份股:
藥明生物(02269.HK) 收64.8元,上升6.1%;
京東健康(06618.HK) 收64.8元,上升4.2%;
海底撈(06862.HK) 收20.85元,上升3.5%;
快手-W(01024.HK) 收98.8元,上升3.3%;
異動綜合中小型股:
東嶽集團(00189.HK) 收10.4元,上升13%;
亞信科技(01675.HK) 收15.22元,上升4%,創新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.